Quantum Cyber N.V.
Sector: Pharmaceutical PreparationsIndustry: Medical - Diagnostics & ResearchCountry: DEExchange: Nasdaq
DilutionScan read 54 of Quantum Cyber N.V.'s SEC filings and found 6 warrant series, 8 convertibles, 3 ATM programs, 1 equity line, 3 shelf registrations, 2 S-1 registrations and 3 completed offerings on file for QUCY. The latest dilution event on file is ATM sales on Oct 9, 2026. Analysis updated Oct 9, 2026.
Signal8 Summary
QUCY
Shell company with no real business
Snapshot
The ticker QUCY is a shell. The listed entity is Mainz Biomed, a German cancer diagnostic firm that generated only $537,000 in revenue last year and lost $16.2 million. It holds just $889,000 in cash against $2.6 million in debt, leaving it with a tight financial position. Meanwhile, the news feed and recent filings describe a completely different company called Quantum Cyber, an autonomous defense firm that just raised $15 million and is building drone factories.
What's Happening Right Now
- : The company signed a letter of intent to buy a 43,000-square-foot manufacturing facility in Connecticut for $3.2 million.
- : Quantum Cyber raised over $15 million by having investors exercise warrants, using the cash to pay off all debt.
- : Quantum Cyber launched a new subsidiary called Quantum Drones Corporation to handle U.S. federal defense contracts.
